Friday 21 April 2017
|09.30-09.40||Arrival, tea and refreshments|
|09.40-10.00||Welcome and introductions, UK-CAB updates, Company pre-meeting (Garry to lead)|
|10.00-11.30||Company meeting: MSD|
|11.45-12.30||Feedback on MSD, Conferences feedback
Conferences feedback: CROI, BHIVA
|15.15-16.00||More CROI feedback; community reps feedback|
|16.10-16.55||Reflection and feedback of the meeting; member updates|
Background reading to follow
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.
The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.